These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20188174)

  • 41. Common themes of dedifferentiation in somatic cell reprogramming and cancer.
    Daley GQ
    Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer stem cells: an old idea--a paradigm shift.
    Wicha MS; Liu S; Dontu G
    Cancer Res; 2006 Feb; 66(4):1883-90; discussion 1895-6. PubMed ID: 16488983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Road for understanding cancer stem cells: model cell lines.
    Serakinci N; Erzik C
    Regen Med; 2007 Nov; 2(6):957-65. PubMed ID: 18034633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Targeted molecular therapy based on advanced cancer stem cell model].
    Hirao A
    Nihon Rinsho; 2015 Aug; 73(8):1256-62. PubMed ID: 26281675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
    Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A
    Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stem-cell hierarchy in skin cancer.
    Perez-Losada J; Balmain A
    Nat Rev Cancer; 2003 Jun; 3(6):434-43. PubMed ID: 12778133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Normal vs cancer thyroid stem cells: the road to transformation.
    Zane M; Scavo E; Catalano V; Bonanno M; Todaro M; De Maria R; Stassi G
    Oncogene; 2016 Feb; 35(7):805-15. PubMed ID: 25961919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic Priming in Cancer Initiation.
    Vicente-Dueñas C; Hauer J; Cobaleda C; Borkhardt A; Sánchez-García I
    Trends Cancer; 2018 Jun; 4(6):408-417. PubMed ID: 29860985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer stem cells: small subpopulation or evolving fraction?
    Enderling H
    Integr Biol (Camb); 2015 Jan; 7(1):14-23. PubMed ID: 25359461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour heterogeneity and cancer cell plasticity.
    Meacham CE; Morrison SJ
    Nature; 2013 Sep; 501(7467):328-37. PubMed ID: 24048065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular Pliancy and the Multistep Process of Tumorigenesis.
    Puisieux A; Pommier RM; Morel AP; Lavial F
    Cancer Cell; 2018 Feb; 33(2):164-172. PubMed ID: 29438693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carcinogenesis is consequence of failure of tissue development.
    Lai S
    Med Hypotheses; 2018 Oct; 119():84-87. PubMed ID: 30122497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment.
    Biava PM; Basevi M; Biggiero L; Borgonovo A; Borgonovo E; Burigana F
    Curr Pharm Biotechnol; 2011 Feb; 12(2):231-42. PubMed ID: 21044002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carcinogenesis driven by bone marrow-derived stem cells.
    Dittmar T; Seidel J; Zaenker KS; Niggemann B
    Contrib Microbiol; 2006; 13():156-169. PubMed ID: 16627964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The hierarchical model of stem cell genesis explains the man mouse paradox, Peto's paradox, the red cell paradox and Wright's enigma.
    Morris JA
    Med Hypotheses; 2014 Dec; 83(6):713-7. PubMed ID: 25459141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular origins of cancer and future cancer therapy].
    Xie L; Hu WJ; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):81-84. PubMed ID: 29502365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular reprogramming in skin cancer.
    Song IY; Balmain A
    Semin Cancer Biol; 2015 Jun; 32():32-9. PubMed ID: 24721247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cells: promises and realities in cancer research.
    García-Olmo D; García-Olmo DC
    Clin Transl Oncol; 2006 May; 8(5):301-2. PubMed ID: 16760002
    [No Abstract]   [Full Text] [Related]  

  • 59. Cell injury, retrodifferentiation and the cancer treatment paradox.
    Uriel J
    Tumour Biol; 2015 Sep; 36(10):7365-74. PubMed ID: 26346166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stem cell fate in cancer growth, progression and therapy resistance.
    Lytle NK; Barber AG; Reya T
    Nat Rev Cancer; 2018 Nov; 18(11):669-680. PubMed ID: 30228301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.